Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
Teicoplanin was evaluated in 47 patients with severe infections, including 14 patients with bone infections, 11 patients with soft-tissue infections, 7 patients with endocarditis, 5 patients with pneumonia, 3 patients with septic thrombophlebitis, 3 patients with septicemia of unknown origin, and 4...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
1986
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180363/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2942100/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.1.52 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
